Richardson, Texas — (April 7, 2022) – MedeAnalytics, a healthcare analytics software-as-a-service (SaaS) leader, announced today the promotion of Andy Dé to Chief Marketing Officer (CMO). Dé has more than 20 years of enterprise software product marketing, product management and innovation strategy experience and is recognized as an industry thought leader in healthcare. In his new role, Dé will oversee the company’s go-to-market (GTM) strategy, planning and execution and lead the global marketing organization reporting to Ryan Smith, Chief Revenue Officer (CRO).
“With Andy’s coveted pedigree of strategy, marketing and thought leadership, we are excited to elevate him to Chief Marketing Officer leading our global marketing organization,” said Steve Grieco, chief executive officer of MedeAnalytics. “Over the last year as a change leader, Andy has led a 360-degree transformation of the marketing function into a world-class, customer value driven organization that is a catalyst for MedeAnalytics’ growth, brand awareness and thought leadership.”
“I am humbled and honored to be recognized with this opportunity and bring my extensive experience in building, transforming and growing world-class, high-performing global marketing teams to enable business growth and market impact,” said Andy Dé, Chief Marketing Officer at MedeAnalytics. “It’s an exciting time at MedeAnalytics as it scales and innovates its SaaS platform, solutions and services to enable growth in mind and market share in healthcare analytics and artificial intelligence (AI) and deliver measurable financial, operational and clinical value and impact for our payer, provider and payvider customers.”
Prior to joining MedeAnalytics, Dé held strategy and marketing leadership positions at leading enterprise software companies and helped create and grow multiple businesses across various industries (manufacturing, supply chain, CPG, airlines, life sciences and healthcare) leading globally dispersed, high-performance teams. He has led six software solutions to market, successfully leveraging his enterprise software innovation strategy, solutions portfolio management, and go-to-market strategy, planning, and execution leadership experience with measurable revenue, margin and pipeline impact.
Most recently, Dé joined MedeAnalytics in March 2021 from Alteryx, where he helped create and grow their healthcare business exponentially as Senior Director of GTM strategy and marketing. He also co-founded and grew the healthcare and life sciences business 5X over four years at Tableau Software. Dé has also held strategy and marketing leadership positions at SAP, GE Healthcare and i2 Technologies.
Dé holds a bachelor’s degree in mechanical engineering from the University of Bombay, India, and a master’s degree in materials science and engineering from the University of Florida. He also holds a master’s degree in international business (I-MBA) from the Tel Aviv International School of Management (TISOM) in Tel Aviv, Israel, and graduated with an MBA from the Richard Ivey School of Business at the University of Western Ontario, in London, Ontario, Canada. In addition, he has completed executive management programs in ‘Disruptive Innovation’ and ‘Strategic Implications of Artificial Intelligence (AI)’ from the Harvard Business School and the MIT-Sloan School of Management, respectively.